Abstract
Introduction: It has been estimated that the prevalence of adenomyosis is 5-70% in Mexico. For the correct study of ade -
nomyosis, the histopathological study of the hysterectomy specimen remains the only confirmatory diagnosis. For this reason,
there are not many current studies that tell us the prevalence of this pathology, which is why it is important to carry out
intentional searches. Objective: T o estimate the prevalence of adenomyosis in patients undergoing total and subtotal hyster
-
ectomy, abdominal, laparoscopic, and vaginal hysterectomy in the period from 2019 to 2021 in Ciudad Juárez and to determine
whether there are clinical factors associated with the presence of adenomyosis. Material and methods: Cross-sectional,
retrospective, descriptive study. This study was conducted in patients who underwent total and subtotal abdominal, laparo
-
scopic, and vaginal hysterectomy, whose histopathological reports were collected from January 2019 to December 2021 .
Patients with a subtotal hysterectomy were excluded. Results: A total of 332 patients were studied, in which a prevalence
of 29.5% was observed, like that established in the general biblio graphy. Conclusions: Adenomyosis is the second gyneco
-
logical pathology in order of frequency, only below leiomyomatosis, by histopathological diagnosis. According to the study,
the clinical profile of patients to be ruled out for adenomyosis would be a history of previous uterine surgery, multiparity, in
the fifth decade of life (specifically between 40 and 50 years of age), overweight, or obese.
Keywords
Adenomyosis. Hysterectomy. Uterine hemorrhage. Uterine diseases. Mexico.
*Correspondence:
Luis A. Pantoja-Quezada
E-mail:
[email protected]
Available online: 01-10-2025
Rev Med Hosp Gen Mex. 2025;88(4):196-201
www.hospitalgeneral.mx
Date of reception: 14-12-2024
Date of acceptance: 03-04-2025
DOI: 10.24875/HGMX.24000096
0185-1063/© 2025 Sociedad Médica del Hospital General de Mexico. Published by Permanyer. This is an open access article under the
CC BY -NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Introduction
Dysfunctional uterine bleeding is the main cause of
bleeding in adult women; its diagnosis is the exclusion
of anatomical alterations, so the clinician must initially
rule out any organic or endocrinological pathology. It is
estimated that around 10 million women in Mexico suffer
from uterine bleeding, and annually, only 6 million of
them seek medical attention
1.
The exact pathogenesis of adenomyosis has not
been established, but some theories have been widely
accepted and adopted by physicians
2. The most com -
mon theory suggests that adenomatosis results from
the invagination of endometrial glands and stroma in
the thickness of the myometrium, together with hyper -
plasia and hypertrophy of smooth muscle fibers of the
latter3. Another possible theory is that the adenomyotic
lesions are due to the metaplasia of displaced Müllerian
remains or to the differentiation of adult stem cells 4.
The prevalence of adenomyosis as an anatomo -
pathological finding is highly variable, ranging from 5%
to 70%, depending on the depth limit considered in the
microscopic finding of foci in myometrial thickness1. Arel-
lano Pichardo et al. in a study carried out in the Mexican
population, they showed that the prevalence of
Revista Médica del
Hospital General de México
C.M. Rivas-Arredondo et al. Adenomyosis in hysterectomized women
197
adenomyosis in hysterectomy specimens was 33.33%
(86 out of 258 patients) 3, as well as a study carried out
in the United States in which a total of 135,162 women
between 16 and 60 years of age were analyzed in 2015,
in which 1,068 women had a previous diagnosis of
adenomyosis. Thus, the prevalence of adenomyosis in
2015 was observed to be 0.8-1.5%; being higher among
women aged 41-45 years
5.
The confirmatory diagnosis requires hysterectomy, in
order to study the entire piece. The minimum distance
required to make the diagnosis has remained under
debate, but ranges from half to two low-power fields
from the endomyometrial junction or a minimum depth
of invasion ranging from 1 to 4 mm. The involvement
of at least 25% to one-third of myometrial thickness is
another diagnostic criterion that has been used in mag -
netic resonance imaging (MRI)
6,7.
Hysterectomy is the only definitive treatment for ade -
nomyosis, which allows us to perform the histopatho -
logical study of the specimen and thus obtain the
microscopic result and obtain the definitive diagnosis
8.
The objective of this study is to determine if there is
an association between clinical variables and the pres -
ence of adenomyosis in patients undergoing total
abdominal and subtotal hysterectomy at the Ciudad
Juárez Women’s Hospital, with the following specific
Objectives
(1) to know the age groups with the highest
frequency of adenomyosis at the Ciudad Juárez Wom -
en’s Hospital, (2) to identify the comorbidities present
in patients diagnosed with adenomyosis at the Wom -
en’s Hospital of Ciudad Juárez, (3) to perform inference
between patients with adenomyosis and without ade -
nomyosis, and (4) to perform a multivariate model to
identify variables associated with the presence of
adenomyosis.
Material and methods
An observational, retrospective, cross-sectional,
descriptive, and analytical study was conducted in 332
women after total and subtotal non-obstetric hysterec -
tomy at the Hospital de la Mujer of Ciudad Juarez, from
January 01, 2019, to December 31, 2021. Clinical
records were reviewed, and a database was built in
Microsoft Excel 2019. As selection criteria, patients
undergoing hysterectomy, both of obstetric and gyne -
cological origin, with total or subtotal technique, from
January 01, 2019 to December 31, 2021, had a histo -
pathological report, as well as patients who had in their
clinical history the variables studied (age, multigesta -
tion, and body mass index [BMI], history of previous
gynecology and obstetrics, adenomyosis, diabetes mel -
litus, and systemic arterial hypertension), as non-inclu -
sion criteria we take patients who are not in the virtual
or physical clinical record, patients whose clinical his -
tory lacks the previously mentioned variables and
finally because they do not have a pathology report.
Statistical analysis
To perform the analysis and graph s of this work, the
statistical program IBM Statistical Packages for the
Social Sciences V.23 for Windows 10 was used. Kolm -
ogorov-Smirnov normality tests were applied to assess
the distribution of variables. The inference analysis for
the quantitative variables was performed using Stu -
dent’s t-test or Mann-Whitney’s U-test, as appropriate,
while Pearson’s Chi-square test was used for the qual -
itative variables. Logistic regression was performed
considering statistically significant variables as inde -
pendent variables for adenomyosis status. The best
model was constructed using the backward step tech -
nique considering Wald’s statistic. A value of p < 0.05
was considered to be statistically significant for all sta -
tistical tests used.
Results
In a sample of 332 women post-operated obstetric
hysterectomy at the Hospital de la Mujer of Ciudad
Juarez, from January 01, 2019 to December 31, 2021 .
A total of 98 (29.5%) patients with histopathological
diagnosis of adenomyosis were detected; in this way, it
was determined that the prevalence of adenomyosis in
the studied population was 29.5% (98 of 332 patients).
The sample found a median age of 45 years with an
interquartile range of 39-50 years. In our sample, a total
of 234 women (70.4%) had a BMI > 25 kg/m
2. A total
of 212 women (63.9%) had a history of cesarean sec-
tion, and 242 (72.9%) were categorized as multigesta-
tion. 19% (63) of the women in this study had a diagnosis
of diabetes and 28.6% (95) had hypertension. Among
the causes of hysterectomy, it was found that 63.6%
(211) were due to uterine myomatosis, 11 .7% (39) were
due to pelvic organ prolapse, 9.9% (33) due to obstetric
hemorrhage, and 6.6% (22) due to placental alteration,
the rest of the causes are described in table 1 .
A total of 98 women (29.5%) had a diagnosis of ade-
nomyosis according to the pathological study (Table 1 ).
Patients were grouped according to the histopathologi -
cal diagnosis of adenomyosis, finding that the median
age in women without adenomyosis was 44 (36-49)
Revista Médica del Hospital General de México. 2025;88(4)
198
while in women with adenomyosis it was 47 (42-50),
p = 0.010 (Fig . 1 ). In the group of women without ade -
nomyosis, 68.8% had a BMI > 25 kg/m 2 and in the
group of women with adenomyosis, 75.5% had a BMI
> 25 kg/m
2 (p = 0.220). Regarding the history of previ -
ous obstetric surgeries, the history was present in
57 .1% of the women in the group with a diagnosis of
adenomyosis, whereas the history was present in 66.7%
of the women without adenomyosis (p = 0.099) (Table 1).
Regarding the categorization of multigest, 73.9% and
70.4% of the group without adenomyosis and with a
diagnosis of adenomyosis were found to be multigest,
respectively (p = 0.510). 18.4% of women without ade -
nomyosis had diabetes, and the same diagnosis
occurred in 20.4% of women with adenomyosis (p =
0.667). 28.6% of women with and without adenomyosis
had hypertension (p = 0.991). 2 logistic models were
performed, in the first (Table 2), all binary variables were
entered, taking the presence of adenomyosis as a
dependent variable, finding statistical significance with
age (B = 0.026 [odds ratio (OR) = 1 .026 95% confidence
interval (CI) = 1 .002-1 .051], p = 0.035). Due to the result
obtained, the elimination of covariates was carried out
using Wald’s statistical criterion (Table 3), finding statis-
tical significance for age (B = 0.026 [OR = 1 .026 95%
CI = 1 .003-1 .049], p = 0.026].
Discussion
Total hysterectomy is the most common gynecolog -
ical surgery in the world. In our study, hysterectomies
performed in 1 year (n = 332) were considered, using
laparotomy, laparoscopy, and vaginality. The type of
surgery to be performed is decided according to the
characteristics of the uterus and the concomitant
pathologies
3,9.
Table 1. General characteristics of the population
Variable Total (%) Adenomyosis (%) p
No (234) Yes (98)
Age (years) 45 (39‑50) 44 (36‑49) 47 (42‑50) 0.010*u
BMI > 25 kg/m 2
Yes
No
235 (70.8)
97 (29.2)
161 (68.8)
73 (31.2)
74 (75.5)
24 (24.5)
0.220
Xi
Previous gynecological and obstetrical surgeries
Yes
No
212 (63.9)
120 (36.1)
156 (66.7)
78 (33.3)
56 (57.1)
42 (42.9)
0.099
Xi
Multigesta
Yes
No
242 (72.9)
90 (27.1)
173 (73.9)
61 (26.1)
69 (70.4)
29 (29.6)
0.510
Xi
Causes of hysterectomy
Placental alteration
Obstetric bleeding
Myomatosis
NIC 1
NIC 2
NIC 3
Oncologic process
Pelvic organ prolapse
Others
22 (6.6)
33 (9.9)
211 (63.6)
3 (0.9)
4 (1.2)
5 (1.5)
8 (2.4)
39 (11.7)
7 (2.1)
19 (8.1)
27 (11.5)
145 (62)
2 (0.9)
4 (1.7)
5 (2.1)
5 (2.1)
22 (9.4)
3 (3.1)
6 (6.1)
66 (67.3)
1 (1)
0 (0)
0 (0)
3 (3.1)
17 (17.3)
0.035*
Xi
Diabetes
Yes
No
63 (19)
269 (81)
43 (18.4)
191 (81.6)
20 (20.4)
78 (79.6)
0.781
Xi
Hypertension
Yes
No
95 (28.6)
268 (81)
67 (28.6)
167 (71.4)
28 (28.6)
70 (71.4)
> 0.999
pXi
This table shows median and IQR 25‑75% and frequency in number and percentage
*: statistical significance (p < 0.05).
u: Mann Whitney´s U test.
Xi: Pearson´s Chi squared.
BMI: body mass index; NIC: neoplasia intraepitelial cervical.
C.M. Rivas-Arredondo et al. Adenomyosis in hysterectomized women
199
In the literature, abnormal uterine bleeding with or
without leiomyomatosis is reported as the main cause
of hysterectomy. Leiomyomatosis is the cause of up to
55%10. In our study, uterine leiomyomatosis was the
most frequent definitive diagnosis, with 211 cases, rep -
resenting 63.5% of the sample, a percentage higher
than what was reported worldwide. Either alone or in
combination with other conditions, was the second
most frequent diagnosis, with a prevalence of 29.5%.
This finding is consistent with global reports, where
prevalence ranges from 2.6% to 70% in pathology
specimens. However, in none of the procedures was
adenomyosis the primary indication for hysterectomy,
as it was diagnosed histopathologically and justified by
other clinical causes
11,12.
Endovaginal ultrasound is the most important imag -
ing technique in gynecological patients. The radiologist
requires experience to identify adenomyosis. This is
explained by the great difficulty in making the prior
diagnosis. There are studies that mention that ultra -
sound and MRI can establish the diagnosis with a
sensitivity of 89%
13-15. However, to suspect adenomyo -
sis, a detailed description of the myometrium described
in the morphological uterus sono graphic assessment
criteria is required, which is not done routinely and only
has the experience of some physicians assigned to
gynecology; for this reason, it is emphasized that each
of these criteria is made known to all personnel and
thus be able to carry out an adequate approach to this
pathology16.
Adenomyosis is a condition with variable frequency
depending on the population studied. It is most com -
monly diagnosed between 40 and 50 years of age,
accounting for up to 80% of cases. For the purposes
of this study, and to better localize the pathology,
patients were grouped by decades. The highest fre -
quency of diagnosis was found in the 40-50-year age
group, with a rate of 63.2%, which is consistent with
findings reported in the global literature
9. Regarding
obstetric history, 70.4% of patients with adenomyosis
were multigested. Patients with 2 or fewer gestates
accounted for 29.6% of reported cases of adenomyo -
sis. According to several authors, most cases of ade -
nomyosis occur in multigestation patients (90%),
consolidating itself as one of the main risk
factors
4,7,17.
Regarding the history of previous uterine surgery and
the presence of adenomyosis, it occurred in 57.1% of
the patients, specifically the history of cesarean section
and instrumented uterine curettage. Uterine trauma
during a cesarean section, curettage, or myomectomy
are the classic risk factors
17. BMI also plays an import -
ant role18. Overweight patients or with some degree of
obesity make up 70.7% of the total number of patients
Table 2. Multiple logistic regression for the presence of
adenomyosis in women after hysterectomy obstetric
Variable B Wald p OR (95% CI)
BMI >
25 kg/m2
0.307 1.189 0.275 1.359 (0.783‑2.359)
Previous
gyneco‑
obstetrical
surgeries
0.306 1.436 0.231 1.358 (0.823‑2.240)
Multigesta −0.259 0.871 0.521 0.772 (0.448‑1.329)
Diabetes 0.111 0.124 0.725 1.117 (0.603‑2.068)
Hypertension −0.188 0.430 0.512 0.829 (0.473‑1.452)
Age 0.026 4.442 0.035* 1.026 (1.002‑1.051)
B: logistic regression coefficient; Wald: Wald statistic; p: value of p;
OR: odds ratio; 95% CI: Confidence interval at 95%. ; BMI: body mass index.
*: statistical significance (p < 0.05).
Table 3. Multiple logistic regression for the presence of
adenomyosis in women after obstetric hysterectomy
Variable B Wald p OR (95% CI)
Age 0.026 4.935 0.026* 1.026 (1.003‑1.049)
B: logistic regression coefficient; Wald: Wald statistic; p: value of p; OR: odds ratio;
95% CI: confidence interval at 95%.
*: statistical significance (p < 0.05).
Figure 1. Age of the patients included in the study
according to diagnosis of adenomyosis. The p value
corresponds to the Mann’s U‑test.
Revista Médica del Hospital General de México. 2025;88(4)
200
studied in our sample, of which 75.5% were diagnosed
with adenomyosis. In adenomyosis, the role of hyper -
estrogenism plays an important role, as it is a risk factor
and is frequently found in overweight or obese women
11.
The presence of diabetes mellitus or systemic arterial
hypertension are variables that in our study, we did not
find with statistical significance, a total of 63 patients
presented a diagnosis of diabetes mellitus (18.9%), of
which twenty presented a diagnosis of adenomyosis
(20.4%), similar figures with systemic arterial hyperten -
sion, in which we have 95 reported cases (28.6%) of
which 28 patients presented a diagnosis of adenomy -
osis (28.6%). However, we found that age is associated
with the presence of adenomyosis (OR = 1.026, [95%
CI = 1.003-1.049], p = 0.026).
Clinical diagnosis is difficult, due to nonspecific signs
and symptoms, which often coexist with other pelvic
diseases
1. In the present study, most of the patients
had abnormal uterine bleeding as their main anteced -
ent; in 73.4% of them, so in all patients with a study
protocol for abnormal uterine bleeding, adenomyosis
should be considered as a diagnostic probability, and
the appropriate protocol for its diagnosis should be
performed.
Currently, there is a limited series of studies, but
important to perform for presurgical diagnosis, which
are, in addition to clinical suspicion, ultrasound and, in
some cases, MRI, this in an attempt by gynecologists
to define the various characteristics resulted in the
criteria for morphological sonograph ic evaluation of
the uterus 19. In these cases, adenomyosis is consid -
ered when the uterus has a globular con figuration and
multiple areas of shadow, sometimes described as
fan-shaped, are visible, with difficulty in differentiating
the myometrium from the junction zone and cystic
changes in the junction zone and myometrium 20. Addi-
tional features that can be observed include an irreg -
ular or interrupted area of conjunction with islands 18,20.
Unfortunately, there are no classic findings on physical
examination or laboratory studies that identify it as a
probable diagnosis
20.
Future applications of artificial intelligence (AI) in
medicine, specifically related to our topic of adenomy -
osis classification 16,18, and need to be discussed. Sys -
tems based on conjunction zone anomalies have shown
promising results in terms of observer agreement and
correlation with clinical symptoms. Recently, there has
been growing interest in the potential of AI to improve
the accuracy and consistency of the diagnosis and
classification of adenomyosis. It has been suggested
that AI-based ultrasound or MRI image analysis could
accurately identify and classify different types of ade -
nomyosis based on the abnormalities of the conjunc -
tion zone16. This approach has the potential to improve
the standardization and reproducibility of presurgical
diagnosis of adenomyosis, as AI algorithms can ana -
lyze large datasets and identify patterns that may not
be immediately apparent to human physicians 15,16,21.
However, as in many areas of medicine, more research
is needed to evaluate these approaches and explore
whether they provide answers to clinically relevant
questions.
Conclusions
The prevalence of adenomyosis at the Ciudad Juárez
Women’s Hospital is 29.4%. Adenomyosis is the second
gynecological pathology in order of frequency, only
below leiomyomatosis, by histopathological diagnosis.
According to the study, the clinical profile of patients to
be ruled out for adenomyosis would be a history of pre -
vious uterine surgery, multiparity, in the fifth decade of
life (specifically between 40 and 50 years of age), over -
weight, or obese. Previous uterine surgery is an import -
ant factor, found in 57.2% of patients. The most common
surgery is cesarean section. It is essential to include in
the study protocol of patients with suspected adenomy -
osis, an ultrasound that includes a complete description
of the myometrium, subendometrial space, and endome-
trium. The outpatient service does not have sonography
equipment, so the diagnosis of adenomyosis is impos -
sible. In none of the patients who underwent hysterec -
tomy was the presence of adenomyosis diagnosed
before the surgical event. Training is required for the
resident and affiliated physicians of our institute due to
the evident lack of knowledge and expertise for the pre -
operative diagnosis of adenomyosis. None of the patients
was the suspicion of adenomyosis contemplated in the
clinical file. Age may be a factor associated with the
presence of adenomyosis; however, more observational
studies are required to corroborate these findings.
Funding
The authors declare that they have not received
funding.
Conflicts of interest
The authors declare no conflicts of interest.
C.M. Rivas-Arredondo et al. Adenomyosis in hysterectomized women
201
Ethical considerations
Protection of humans and animals. The authors
declare that no experiments involving humans or ani -
mals were conducted for this research.
Confidentiality, informed consent, and ethical
approval. The authors have obtained approval from the
Ethics Committee for the analysis of routinely obtained
and anonymized clinical data, so informed consent was
not necessary. Relevant guidelines were followed.
Declaration on the use of artificial intelligence.
The authors declare that no generative artificial intelli -
gence was used in the writing of this manuscript.
References
1. Ibarra Chavarría V, Plasencia Lira J. Diagnóstico y Tratamiento de la
Hemorragia Uterina Disfuncional. Ciudad de México: Secretaría de
Salud; 2013. Available from: https://www.gob.mx/cms/uploads/attach
-
ment/file/28954/HemorragiaUterinaDisfuncional.pdf [Last accessed on
2024 Oct 18].
2. Shubham D, Kawthalkar AS. Critical evaluation of the PALM-COEIN
classification system among women with abnormal uterine bleeding in
low-resource settings. Int J Gynaecol Obstet. 2018;141:217-21.
3. Arellano Pichardo EI, Labastida Torres J. Prevalencia de Adenomiosis
en Piezas Quirúrgicas de Histerectomía y Factores de Riesgo Clínicos
Relacionados. Ciudad de México; 2018. Available from: https://www.
medigraphic.com/cgi-bin/new/resumen.cgi?IDARTICULO=80497 [Last
accessed on 2024 Oct 18].
4. Bulun SE, Yildiz S, Adli M, Wei JJ. Adenomyosis pathogenesis: insights
from next-generation sequencing. Hum Reprod Update. 2021;27:1086-97.
5. Yu O, Schulze-Rath R, Grafton J, Hansen K, Scholes D, Reed SD, et al.
Adenomyosis incidence, prevalence and treatment: United States popu
-
lation-based study 2006-2015. Am J Obstet Gynecol. 2020;222:94.e1-10.
6. Zhai J, Vannuccini S, Petraglia F, Giudice LC. Adenomyosis: mecha -
nisms and pathogenesis. Semin Reprod Med. 2020;38:129-43.
7. Moawad G, Kheil MH, Ayoubi JM, Klebanoff JS, Rahman S, Sharara FI.
Adenomyosis and infertility. J Assist Reprod Genet. 2022;39:1027-31.
8. Pirtea P, De Ziegler D, Ayoubi JM. Endometrial receptivity in adenomyo -
sis and/or endometriosis. Fertil Steril . 2023;119:741-5.
9. Falcone T, Flyckt RL. Clinical management of endometriosis. Obstet
Gynecol. 2018;131:557-71.
10. Güzel AI, Akselim B, Erkilinç S, Kokanali K, Tokmak A, Dolmuş B, et al.
Risk factors for adenomyosis, leiomyoma and concurrent adenomyosis
and leiomyoma. J Obstet Gynaecol Res. 2015;41:932-7.
11. Vannuccini S, Petraglia F. Recent advances in understanding and mana -
ging adenomyosis. F1000Res. 2019;8:F1000 Faculty Rev-283; pages. 2-10.
12. Di Donato N, Montanari G, Benfenati A, Leonardi D, Bertoldo V, Monti G,
et al. Prevalence of adenomyosis in women undergoing surgery for
endometriosis. Eur J Obstet Gynecol Reprod Biol. 2014;181:289-93.
13. Cunningham RK, Horrow MM, Smith RJ, Springer J. Adenomyosis: a
sonographic diagnosis. Radiographics. 2018;38:1576-89.
14. Moawad G, Fruscalzo A, Youssef Y, Kheil M, Tawil T, Nehme J, et al.
Adenomyosis: an updated review on diagnosis and classification. J Clin
Med. 2023;12:4828.
15. Struble J, Reid S, Bedaiwy MA. Adenomyosis: a clinical review of a cha
-
llenging gynecologic condition. J Minim Invasive Gynecol. 2016;23:164-85.
16. Canis M, Gremeau AS, Bourdel N. Elusive adenomyosis: a plea for an
international classification system to allow artificial intelligence approa
-
ches to reset our clinical management. Fertil Steril. 2018;110:1039-40.
17. Rocha TP, Andres MP, Borrelli GM, Abrão MS. Fertility-sparing treatment
of adenomyosis in patients with infertility: a systematic review of current
options. Reprod Sci. 2018;25:480-6.
18. Raimondo D, Raffone A, Aru AC, Giorgi M, Giaquinto I, Spagnolo E, et al.
Application of deep learning model in the sonograph ic diagnosis of ute
-
rine adenomyosis. Int J Environ Res Public Health. 2023;20:1724.
19. Lazzeri L, Morosetti G, Centini G, Monti G, Zupi E, Piccione E, et al.
A sono graphic classification of adenomyosis: interobserver reproducibility
in the evaluation of type and degree of the myometrial involvement.
Fertil Steril. 2018;110:1154-61.e3.
20. Abbott JA. Adenomyosis and abnormal uterine bleeding
(AUB-A)-pathogenesis, diagnosis, and management. Best Pract Res Clin
Obstet Gynaecol. 2017;40:68-81.
21. Harmsen MJ, Van den Bosch T, De Leeuw RA, Dueholm M, Exacoustos C,
Valentin L, et al. Consensus on revised definitions of morphological
uterus sonographic assessment (MUSA) features of adenomyosis: results
of modified Delphi procedure. Ultrasound Obstet Gynecol. 2022;60:118-31.
Text is read by the "Ask this paper" AI Q&A widget below.
Extraction quality varies by source — PMC NXML preserves structure
cleanly, OA-HTML may include some navigation residue, and OA-PDF can
have broken hyphenation. The publisher copy
(via DOI)
is the canonical version.